Clinical Trial Update: Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enteric-coated mycophenolate sodium with steroid withdrawal versus standard steroid regimen in de novo kidney transplant recipients has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Enteric-coated Mycophenolate Sodium (EC-MPS) (mycophenolate sodium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney de Novo Transplant | Phase 3 | Status: COMPLETED